Q2 2019 13F Holders as of 30 Jun 2019
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
58,958,882
-
Share change
-
+1,980,071
-
Total reported value
-
$452,049,848
-
Put/Call ratio
-
64%
-
Price per share
-
$7.67
-
Number of holders
-
156
-
Value change
-
+$2,893,545
-
Number of buys
-
92
-
Number of sells
-
73
Institutional Holders of ACORDA THERAPEUTICS INC - COM (ACOR) as of Q2 2019
As of 30 Jun 2019,
ACORDA THERAPEUTICS INC - COM (ACOR) was held by
156 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
58,958,882 shares.
The largest 10 holders included
FMR LLC, BlackRock Inc., VANGUARD GROUP INC, RENAISSANCE TECHNOLOGIES LLC, STATE STREET CORP, DIMENSIONAL FUND ADVISORS LP, SCOPIA CAPITAL MANAGEMENT LP, BAKER BROS. ADVISORS LP, ACADIAN ASSET MANAGEMENT LLC, and PERCEPTIVE ADVISORS LLC.
This page lists
156
institutional shareholders reporting positions in this security
for the Q2 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.